Tuberculosis patient treatment adherence. Tuberculosis of lung, bacteriologically and histologically negativeTuberculous: bronchiectasis, fibrosis of lung, pneumonia, pneumothorax, bacteriologically and histologically negative
Conditions
Interventions
Patient will be given GRVOTS mobile apps that enable them to virtually record their medication intake via Video Direct Observed Therapy (VDOTS) as a method to monitor their medication adherence dail
Sponsors
World Health Organization
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Ability to speak and read English or BM Working-aged TB patients (19-64 years old) Newly diagnosed with PTB (first-line treatment) Has completed the in-person DOT at least two weeks (ensuring medications tolerance) Willing and able to provide informed consent Knowledge in smartphone and apps usage
Exclusion criteria
Exclusion criteria: Patients with drug-resistant TB Patients with health conditions that disallow them to use a smartphone (severe arthritis, vision impairment) Patients with no knowledge of smartphone usage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of video received via the mobile apps (VDOTS). Timepoint: Baseline (before intervention) and 4 and 8 weeks after intervention. Method of measurement: Number of video (VDOTS) received.;Medication Adherence Score. Timepoint: Baseline (before intervention) and 4 and 8 weeks after intervention. Method of measurement: My MAAT (Malaysian Medication Adherence Assessment Tools).;Motivation Score. Timepoint: Baseline (before intervention) and 4 and 8 weeks after intervention. Method of measurement: Intrinsic Motivation Inventory (IMI Tools). | — |
Countries
Malaysia
Contacts
Public ContactNurhuda Ismail
Universiti Teknologi MARA
Outcome results
None listed